SPDR S&P Pharmaceuticals ETF
XPH
XPH
75 hedge funds and large institutions have $224M invested in SPDR S&P Pharmaceuticals ETF in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 10 increasing their positions, 27 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
63% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 27
Holders
75
Holding in Top 10
–
Calls
$3.94M
Puts
–
Top Buyers
| 1 | +$38.8M | |
| 2 | +$1.88M | |
| 3 | +$1.88M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.38M |
| 5 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$1.33M |
Top Sellers
| 1 | -$50.4M | |
| 2 | -$17.3M | |
| 3 | -$14M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.17M |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$1.06M |